CLINICAL_TRIALS
trial_result
· 2013-10-21
Clinical Trial Update: The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer [NA]
Summary
A terminated clinical trial evaluated Sorafenib in Barrett's Esophagus-associated esophageal cancer, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Esophageal Cancer | NA | Status: TERMINATED | Results posted: 2013-10-21